World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12616000845437
Date of registration: 28/06/2016
Prospective Registration: No
Primary sponsor: Tanka Prasad Bohara
Public title: Role of Neutrophil Lymphocyte Ratio in Early Detection of Septic Complications After Major Operations
Scientific title: Role of Neutrophil Lymphocyte Ratio in Early Detection of Septic Complications After Major Operations
Date of first enrolment: 19/04/2016
Target sample size: 122
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12616000845437.aspx
Study type:  Observational
Study design:  Purpose: Screening;Duration: Cross-sectional;Selection: Convenience sample;Timing: Prospective;  
Phase:  Not Applicable
Countries of recruitment
Nepal
Contacts
Name: Dr Tanka Prasad Bohara   
Address:  Department of Surgery Kathmandu Medical College Teaching Hospital 184, Babu Ram Acharya Sadak Sinamangal Kathmandu Nepal 44600 Nepal
Telephone: +9779841352378
Email: tankaprasad.bohara@gmail.com
Affiliation: 
Name: Dr Tanka Prasad Bohara   
Address:  Department of Surgery Kathmandu Medical College Teaching Hospital 184, Babu Ram Acharya Sadak Sinamangal Kathmandu Nepal 44600 Nepal
Telephone: +9779841352378
Email: tankaprasad.bohara@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients undergoing major operations requiring intensive care unit admission postoperatively.
Operations involving opening of the body cavities will be considered as major operations. Operations involving abdomen and chest will be included in this study.

Exclusion criteria: Patients undergoing emergency operations
Pre- operative use of anti-inflammatory drugs
Pre-operative use of chemotherapy and steroids
Patients with haematological malignancy
Patient not giving consent for the study


Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Infection - Other infectious diseases
Surgery - Other surgery
Post operative sepsis;
Post operative sepsis
Intervention(s)
Patients undergoing major operations that require post-operative intensive care unit care will be observed for development of postoperative sepsis.
Routine blood investigations are sent daily in the intensive care unit. We will calculate neutrophil-lymphocyte count from the complete blood count sent as a routine investigation. We will calculate neutrophil lymphocyte ratio on post-operative day 1 and day 2 and follow up the participants till discharge from the hospital.
Primary Outcome(s)
Neutrophil Lymphocyte Ratio will be calculated as ratio of Neutrophil to Lymphocyte count.
The value of this ratio will be compared between the groups of patient with and without postoperative sepsis.
[Neutrophil Lymphocyte Ratio will be calculated on the postoperative day 1 and 2. ]
Postoperative sepsis
Post-operative sepsis will be defined as per ACCP/SCCM guidelines.
Sepsis The systemic response to infection, manifested by two or more of the following conditions: (1) temperature >38 degree Celsius or <36 degree Celsius (2;) heart rate >90 beats per minute; (3) respiratory rate >20 breaths per minute or PaCO2, <32 mm Hg; and (4) white blood cell count >12,000/cu mm, <4,000/cu mm, or >10% immature (band) forms.

All patients with suspected sepsis will be worked up to identify the source of sepsis with chest x-ray, sputum gram stain and culture sensitivity (if Chest X-ray is suggestive of pneumonia), urinary routine and culture sensitivity,ultrasound / computed tomography and other investigations will be done if clinically indicated Urinary tract infection will be diagnosed based on presence of pus cell >3 0r more White blood cell in unspun urine sample in microscopic examination and/or positive urine culture. Pneumonia will be diagnosed if the chest x-ray shows infiltrate and/or presence of pus cells in gram’s stain and positive sputum culture. Abscess or peritonitis will be diagnosed based on clinical and radiological examination


Reference
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest. 2009 Nov;136(5 Suppl):e28 [The patient will be assessed daily till the time of discharge from ICU. ]
Secondary Outcome(s)
SIRS without sepsis
SIRS will be defined as per ACCP/SCCM guidelines.
Systemic inflammatory response syndrome (SIRS) The systemic inflammatory response to a variety of severe clinical insults. The response is manifested by two or more of the following conditions:
(1) temperature >38 degree Celsius or <36 Celsius C(2;) heart rate >90 beats per minute; (3) respiratory rate >20 breaths per minute or PaCO2, <32 mm Hg; and (4) white blood cell count >12,000/cu mm, <4,000/cu mm, or >10% immature (band) forms.

[The patient will be assessed daily till the time of discharge from ICU.]
Secondary ID(s)
None
Source(s) of Monetary Support
Tanka Prasad Bohara
Secondary Sponsor(s)
Uttam Laudari
Ethics review
Status: Approved
Approval date:
Contact:
Kathmandu Medical College Public Ltd. Institutional Review Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history